Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1967 1
1969 1
1975 1
1979 1
1980 6
1981 6
1982 2
1984 1
1987 1
1989 1
1990 1
1991 1
1993 1
1994 1
1999 3
2000 3
2001 4
2002 4
2003 3
2004 7
2005 2
2006 7
2007 5
2008 5
2009 4
2010 6
2011 6
2012 8
2013 9
2014 8
2015 4
2016 4
2017 5
2018 4
2019 7
2020 7
2021 10
2022 13
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).
Weber JS, Schadendorf D, Del Vecchio M, Larkin J, Atkinson V, Schenker M, Pigozzo J, Gogas H, Dalle S, Meyer N, Ascierto PA, Sandhu S, Eigentler T, Gutzmer R, Hassel JC, Robert C, Carlino MS, Di Giacomo AM, Butler MO, Muñoz-Couselo E, Brown MP, Rutkowski P, Haydon A, Grob JJ, Schachter J, Queirolo P, de la Cruz-Merino L, van der Westhuizen A, Menzies AM, Re S, Bas T, de Pril V, Braverman J, Tenney DJ, Tang H, Long GV. Weber JS, et al. Among authors: re s. J Clin Oncol. 2023 Jan 20;41(3):517-527. doi: 10.1200/JCO.22.00533. Epub 2022 Sep 26. J Clin Oncol. 2023. PMID: 36162037 Free PMC article. Clinical Trial.
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma.
Robert C, Long GV, Brady B, Dutriaux C, Di Giacomo AM, Mortier L, Rutkowski P, Hassel JC, McNeil CM, Kalinka EA, Lebbé C, Charles J, Hernberg MM, Savage KJ, Chiarion-Sileni V, Mihalcioiu C, Mauch C, Arance A, Cognetti F, Ny L, Schmidt H, Schadendorf D, Gogas H, Zoco J, Re S, Ascierto PA, Atkinson V. Robert C, et al. Among authors: re s. J Clin Oncol. 2020 Nov 20;38(33):3937-3946. doi: 10.1200/JCO.20.00995. Epub 2020 Sep 30. J Clin Oncol. 2020. PMID: 32997575 Free PMC article. Clinical Trial.
Replica-Exchange Methods for Biomolecular Simulations.
Sugita Y, Kamiya M, Oshima H, Re S. Sugita Y, et al. Among authors: re s. Methods Mol Biol. 2019;2022:155-177. doi: 10.1007/978-1-4939-9608-7_7. Methods Mol Biol. 2019. PMID: 31396903
Molecular Basis for Two Stereoselective Diels-Alderases that Produce Decalin Skeletons*.
Fujiyama K, Kato N, Re S, Kinugasa K, Watanabe K, Takita R, Nogawa T, Hino T, Osada H, Sugita Y, Takahashi S, Nagano S. Fujiyama K, et al. Among authors: re s. Angew Chem Int Ed Engl. 2021 Oct 4;60(41):22401-22410. doi: 10.1002/anie.202106186. Epub 2021 Jul 5. Angew Chem Int Ed Engl. 2021. PMID: 34121297 Free PMC article.
163 results